Hold at $262: Constructive Fundamentals but Premature to Add Without Technical Confirmation
Hold TXN rather than Underweight because the structural thesis (liquidity, cash generation, Dividend Aristocrat status, $11.3B trailing operating cash flow, ~35% ROE, $324.45 fair-value estimate) and $234 200-SMA support have not been invalidated. Do not add at current ~$262 level despite lower-Bollinger/ATR-compression setup, as the technical damage (below 10 EMA near $267 and 50 SMA near $286, negative accelerating MACD, 29.8M-share June distribution event without comparable accumulation) and fundamental headwinds (gross margin ~1,050 bps below 2022 peak, ~$14B debt, interest expense rose to $543M in 2025 from $214M in 2022, 86% dividend payout ratio) make premature deployment unjustified. Prior TXN decisions validate patience: multiple Hold calls avoided premature adds at broken intermediates while aggressive 8/7 Overweight incurred negative alpha. Full Sell is unwarranted given the visible FCF inflection and longer-term $320-$324.45 target range supported by improving utilization.
| Position | Action |
|---|---|
| Weekly close below $234 | Reduce or exit position |
| Confirmed $234-$245 200-SMA test with reversal/accumulation evidence | Add to position |
| Close above $267 followed by volume-confirmed reclaim of $286-$288 | Add to position |
| Price at $275 or higher | Sell covered calls if consistent with portfolio mandate |
TXN's combination of accelerating fundamentals, collapsing capital intensity, and technical positive divergence creates a compelling risk-reward setup with ~24% upside to fair value versus ~10% downside to the 200-day SMA.
| Indicator | Value | Signal |
|---|---|---|
| 10 EMA | $267.04 | bearish |
| 50 SMA | $286.60 | bearish |
| 200 SMA | $233.95 | bullish |
| RSI | 39.03 | bearish |
| MACD Line | -6.56 | bearish |
| MACD Signal Line | -5.29 | bearish |
| MACD Histogram | -1.26 | bearish |
| Bollinger Upper Band | $290.17 | neutral |
| Bollinger Middle Band | $273.63 | neutral |
| Bollinger Lower Band | $257.09 | neutral |
| ATR |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Close above $267 followed by volume-confirmed reclaim of $286-$288
Then: Add to position
↩ rebuts: “Post-earnings weakness framing — the 6.8% drawdown occurred during accelerating fundamentals, not deteriorating ones”
EV: +24% · concedes: Only 8% recession risk priced for end-2026 — cyclical recovery thesis remains intact; Trailing P/E is 39.8x — an artifact of 2023-2024 cyclical trough; Elevated debt of $14B acknowledged, but framed as 'cost of building a manufacturing moat that's now complete'; Near-term technicals show 'bearish stack' — Price < 10 EMA < 50 SMA on short-term tape; Short-term entry point is uncertain (current levels $260-265 zone)
TXN is a value trap at $261 — the parabolic rally from $170 to $332 was institutional distribution, not accumulation, and the correction to fair value isn't complete.
EV: -10% to -15% · concedes: TXN is a great company (not a great stock at this price); CapEx has peaked (already priced in); Price is $27 above the 200 SMA (long-term uptrend technically intact); Some RSI divergence potential exists (unconfirmed); Positive divergence on oscillators is a tentative early-stage signal (hasn't confirmed)
→ vs conservative: Citing 29.8M share session on June 26 as institutional distribution is a category error; distribution at $332 does not mean distribution at $261, and trimming 25-50 percent hands shares to fundamentally backed institutional bid at attractive valuation
→ vs neutral: Waiting for two confirmations before adding on a base-building name with RSI divergence, lower Bollinger test, and 29 percent ATR compression means chasing at $280-$290 when the coiled spring releases to the upside
| 9.67 |
| neutral |
| VWMA | $273.36 | bearish |
| Close | $261.77 | neutral |
Support: 257.09 · 233.95 | Resistance: 273.63 · 286.6 · 290.17
TXN is in a confirmed medium-term downtrend with a "bearish stack" structure (Price $261.77 < 10 EMA $267.04 < 50 SMA $286.60). The stock has corrected approximately 21% from the June 22, 2026 peak of $332.33 and is currently testing the lower Bollinger Band at $257.09. While the 200 SMA at $233.95 maintains long-term uptrend integrity, all short and medium-term indicators remain bearish with MACD histogram deepening to -1.26 and RSI at 39.03 approaching oversold territory. The final transaction proposal is HOLD with risk-management stops for existing longs, awaiting reversal confirmation before new entries.
Market Cap
$239.06 billion
P/E Ratio (TTM)
39.78x
Forward P/E
24.59x
PEG Ratio
1.17
Price/Book
13.27x
EPS (TTM)
$6.58
Forward EPS
$10.64
Forward EPS Growth
+62%
Dividend Yield
2.18%
Dividend Per Share
$5.65
Dividend Payout Ratio
~86%
52-Week High
$334.03
52-Week Low
$152.73
50-Day Moving Avg
$288.57
200-Day Moving Avg
$235.45
Beta
1.325
Gross Margin (TTM)
58.3%
Operating Margin (TTM)
42.6%
Net Margin
31.1%
Return on Equity (ROE)
35.2%
Return on Assets (ROA)
13.1%
Q2 2026 Revenue
$5,463M
Q2 2026 EPS
$2.14
Q2 2026 Operating Income
$2,327M
Q2 2026 Free Cash Flow
$2,189M
Q2 2026 CapEx
$514M
TTM Revenue
$19,453M
TTM Free Cash Flow
$3.55B
TTM Operating Cash Flow
$8.5B
2025 Revenue
$17,682M
2024 Revenue
$15,641M
2023 Revenue
$17,519M
2022 Revenue
$20,028M
2021 Revenue
$20,028M
Total Assets
$35,882M
Total Debt
$14.05B
Net Debt
$10.39B
Cash and Short-Term Investments
$7.00B
Total Debt / Equity
78.0%
Current Ratio
4.86
Book Value Per Share
$19.72
Working Capital
$12.5B
Inventory
$4.6B
Goodwill
$4.33B
Net PP&E
$11.91B
Interest Expense (2025)
$543M
2025 CapEx
$4,550M
2024 CapEx
$4,820M
2023 CapEx
$5,071M
2022 CapEx
$2,797M
2025 Free Cash Flow
$2,603M
2022 Free Cash Flow
$5,923M
2025 Dividends Paid
$5.0B
2025 Buybacks
$1,477M
Cumulative Buybacks
~$42B
Cumulative CapEx (2022-2025)
~$17B
R&D (Q2 2026)
$535M
SG&A (Q2 2026)
$490M
Gross Margin (2022 Peak)
68.8%
Operating Margin (2022 Peak)
51.9%
Strengths
Concerns
Texas Instruments is a high-quality cyclical semiconductor franchise in early-to-middle innings of recovery, with Q2 2026 delivering record revenue of $5,463M (+22.8% YoY) and EPS of $2.14 (+51.8% YoY). The key fundamental catalyst is capex declining from ~$1.3B in Q2 2025 to $514M in Q2 2026, which should drive free cash flow from $3.55B TTM to potentially $8B+ by 2027-2028 as revenue grows while capex normalizes. Forward EPS of $10.64 implies 62% EPS growth potential, supporting a reasonable 24.6x forward P/E valuation. The company maintains a strong balance sheet with $7B+ liquidity, a 4.86 current ratio, and investment-grade BBB+ rating, while the 2.18% dividend yield provides a yield-supported floor for long-term investors. Risks include high cyclicality in industrial/automotive end markets, $14B elevated debt load with rising interest costs, $4.6B inventory overhang, and above-market volatility (beta 1.33).
Macro: Fed priced to hold rates with 87% probability of zero cuts in 2026 (Polymarket, $7.5M volume), US recession risk priced at just 8% by end-2026 (up 0.5pp in one week), PCE inflation picking up per Wall Street Journal (8/26), 10Y yield likely elevated/sticky with front-end anchored given no-cut odds and rising inflation. Low recession risk supports cyclical end-market recovery; higher-for-longer rates favor cash-generative defensive names like TXN over high-multiple growth names. Copper at 52-week highs signals healthy industrial demand supporting TXN's ~40% industrial exposure.